Global HLA Typing Transplant Market 2017-2021

HLA(ヒト白血球抗原)判定・移植の世界市場2017-2021

◆タイトル:Global HLA Typing Transplant Market 2017-2021
◆商品コード:IRTNTR12635
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年4月19日
◆ページ数:70
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、HLA(ヒト白血球抗原)判定・移植の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、HLA(ヒト白血球抗原)判定・移植の世界市場規模及び予測、技術別分析、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

ABSTRACTAbout HLA Typing Transplant

Human leukocyte antigen (HLA) is located in the chromosome 6, which is present in almost all nucleated cells. The HLA system includes a complex array of genes, which controls the immune response through recognition of self and non-self antigens, which can lead to graft rejection. HLA typing, also known as tissue typing, is required majorly to examine graft rejection due to organ, tissue, blood cell, and bone marrow transplantation. Through this testing, bone marrow and blood cell transplantation complications can be minimized, which can increase the survival rate of the organ recipient.

Technavio’s analysts forecast the global HLA typing transplant market to grow at a CAGR of 9.20% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global HLA typing transplant market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of products such as systems, assays, and accessories.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global HLA Typing Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Immucor
• Illumina
• Thermo Fisher Scientific

[Other prominent vendors]
• Biofortuna
• Bio-Rad Laboratories
• Cellular Technology
• GenDx
• HistoGenetics
• InGen
• Linkage Biosciences
• Omixon
• Pacific Biosciences of California
• STRATEC Biomedical

[Market driver]
• Growing incidence of organ failure
• For a full, detailed list, view our report

[Market challenge]
• High cost of transplantation and unfavorable reimbursement policies
• For a full, detailed list, view our report

[Market trend]
• New government initiatives for HLA typing
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights
• Overview of HLA

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by products
• Global HLA typing transplant market by systems and software
• Global HLA typing transplant market by reagents and accessories

PART 07: Market segmentation by technology

PART 08: Market segmentation by end-user
• Hospitals and transplant centers
• Donor registries and research laboratories

PART 09: Geographical segmentation
• HLA typing transplant market in Americas
• HLA typing transplant market in EMEA
• HLA typing transplant market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Evolving sales strategies of vendors with changing market dynamics
• New government initiatives for HLA typing
• New product approvals and launches

PART 13: Vendor landscape
• Competitive landscape

PART 14: Key vendor analysis
• Immucor
• Illumina
• Thermo Fisher Scientific
• Key companies to watch out for
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Types of HLA and their LOCi
Exhibit 02: NGS and traditional sequencing
Exhibit 03: Kidney and liver transplantation: Number of deceased and living donors 2014
Exhibit 04: Global HLA typing transplant market 2016-2021 ($ millions)
Exhibit 05: Strategies for new entrants and present companies in market
Exhibit 06: Five forces analysis
Exhibit 07: Market overview: Systems
Exhibit 08: Market overview: Software
Exhibit 09: Global HLA typing transplant market by systems and software 2016-2021 ($ millions)
Exhibit 10: Market impact analysis and product dynamics of HLA typing systems and software
Exhibit 11: Market overview: Reagents and accessories
Exhibit 12: Global HLA typing transplant market for reagents and accessories 2016-2021 ($ millions)
Exhibit 13: Market impact analysis and product dynamics of HLA typing reagents and accessories
Exhibit 14: Global HLA typing transplant market by technology 2016
Exhibit 15: Global HLA typing transplant market by end-user 2016
Exhibit 16: Global HLA typing transplant market by geography in 2016 and 2021 ($ millions)
Exhibit 17: Market overview: HLA typing transplant market in Americas
Exhibit 18: Survival probability of Diamond–Blackfan anemia patients in US 2008-2012
Exhibit 19: HLA typing transplant market in Americas 2016-2021 ($ millions)
Exhibit 20: HLA typing transplant market in Americas: Market analysis in various countries
Exhibit 21: Types of organ transplantation in US (2015)
Exhibit 22: Market overview: HLA typing transplant market in US
Exhibit 23: Market overview: HLA typing transplant market in EMEA
Exhibit 24: Profiles of key transplant centers in Europe
Exhibit 25: HLA typing transplant market in EMEA 2016-2021 ($ millions)
Exhibit 26: HLA typing transplant market in EMEA: Market analysis in various countries
Exhibit 27: Market overview: HLA typing transplant market in UK
Exhibit 28: Market overview: HLA typing transplant market in APAC
Exhibit 29: HLA typing transplant market in APAC 2016-2021 ($ millions)
Exhibit 30: HLA typing transplant in APAC: Market analysis in various countries
Exhibit 31: Market overview: HLA typing transplant market in Australia
Exhibit 32: Market impact analysis: Technology advancements
Exhibit 33: Number of hospitals merged and acquired between 2010 and 2015 in US
Exhibit 34: Impact of drivers
Exhibit 35: Average cost of transplantation procedure
Exhibit 36: Average cost of sequencers of different companies
Exhibit 37: Legal and ethical issues in countries for solid organ transplantation
Exhibit 38: Impact of challenges
Exhibit 39: Strategies of vendors in global HLA typing transplant market
Exhibit 40: Government programs and its market impact in few countries
Exhibit 41: Competitive structure analysis of global HLA typing transplant market 2016
Exhibit 42: Competitive landscape of global HLA typing transplant market 2016
Exhibit 43: Strategies for large and small companies in global HLA typing transplant market
Exhibit 44: Immucor: Strength assessment
Exhibit 45: Immucor: Strategy assessment
Exhibit 46: Immucor: Opportunity assessment
Exhibit 47: Illumina: Strength assessment
Exhibit 48: Illumina: Strategy assessment
Exhibit 49: Illumina: Opportunity assessment
Exhibit 50: Thermo Fisher Scientific: Strength assessment
Exhibit 51: Thermo Fisher Scientific: Strategy assessment
Exhibit 52: Thermo Fisher Scientific: Opportunity assessment



【掲載企業】

Immucor, Illumina, Thermo Fisher Scientific, Biofortuna, Bio-Rad Laboratories, Cellular Technology, GenDx, HistoGenetics, InGen, Linkage Biosciences, Omixon, Pacific Biosciences of California and STRATEC Biomedical.

【資料のキーワード】

HLA(ヒト白血球抗原)、HLA判定、組織型別、移植

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[HLA(ヒト白血球抗原)判定・移植の世界市場2017-2021] (Global HLA Typing Transplant Market 2017-2021 / IRTNTR12635)販売に関する免責事項
[HLA(ヒト白血球抗原)判定・移植の世界市場2017-2021] (Global HLA Typing Transplant Market 2017-2021 / IRTNTR12635)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆